---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-069925"
form_type: "8-K"
ticker: "ALBT"
cik: "0001630212"
company_name: "Avalon GloboCare Corp."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:45:33.330979+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Avalon GloboCare to acquire 60% of Laboratory Services MSO for up to $31M; appoints Sarah Cox as COO

## Summary
- Up to $31M total consideration: $5M prepaid, $10M cash at close, $15M in Series B Preferred (convertible at $0.575/sh), $1M anniversary payment, plus earnouts up to $10M.
- Private placement of Series A Preferred raises $5M; additional $10M issuance planned to fund remaining cash portion.
- Sarah Cox (CEO of Lab MSO) appointed COO of Avalon and director; Meng Li resigns as director.
- Closing expected in ~30 days, subject to financing and stockholder approval for conversion shares.

## SEC filing metadata
- accession: 0001213900-22-069925
- form_type: 8-K
- ticker: ALBT
- cik: 0001630212
- company_name: Avalon GloboCare Corp.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/0001213900-22-069925-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/ea167589-8k_avalonglob.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-069925
- JSON: https://secwatch.observer/filing/0001213900-22-069925.json
- Plain text: https://secwatch.observer/filing/0001213900-22-069925.txt

## Key facts
- Governance Changes
  Avalon GloboCare Corp.: Filed a Certificate of Designation for Series A Preferred Stock with the Delaware Secretary of State, effective immediately on November 3, 2022 (effective 2022-11-03).
  - Change: charter amendment
  - Effective: 2022-11-03
  source text: on November 3, 2022 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock (the “ Series A Certificate of Designation ”), which became effective immediately with the Secretary of State of the State of Delaware
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/0001213900-22-069925-index.htm
- Material Agreements
  Avalon GloboCare Corp. entered into Membership Interest Purchase Agreement with SCBC Holdings LLC valued at up to thirty-one million dollars ($31,000,000) (effective 2022-11-07).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: SCBC Holdings LLC
  - Value: up to thirty-one million dollars ($31,000,000)
  - Effective: 2022-11-07
  source text: On November 7, 2022, Avalon Laboratory Services, Inc. (the “ Buyer ”), a wholly-owned subsidiary of Avalon GloboCare Corp. (the “ Company ”), entered into a Membership Interest Purchase Agreement (the “ MIPA ”), by and among SCBC Holdings LLC (the “ Seller ”), the Zoe Family Trust, and Bryan Cox and Sarah Cox as individuals (each an “ Owner ” and collectively, the “ Owners ”), and Laboratory Services MSO, LLC (“ Laboratory Services MSO ”), pursuant to which, subject to the terms and conditions set forth in the MIPA, the Buyer will acquire from the Seller, sixty percent (60%) of all the issued and outstanding equity interests of the Laboratory Services MSO (the “ Purchased Interests ”), free and clear of all liens (the “ Transaction ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/0001213900-22-069925-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.